{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:58:57Z","timestamp":1793051937404,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.beem.2012.11.004","type":"journal-article","created":{"date-parts":[[2012,12,25]],"date-time":"2012-12-25T16:05:59Z","timestamp":1356451559000},"page":"3-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":238,"title":["History of oral contraceptive drugs and their use worldwide"],"prefix":"10.1016","volume":"27","author":[{"given":"Sophie","family":"Christin-Maitre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2012.11.004_bib1","series-title":"Planned parenthood","author":"Knowles","year":"2006"},{"key":"10.1016\/j.beem.2012.11.004_bib2","first-page":"29","article-title":"Ever since Eve: birth control in the ancient world","volume":"47","author":"Riddle","year":"1994","journal-title":"Archaeology"},{"key":"10.1016\/j.beem.2012.11.004_bib3","series-title":"Woman of Valor: Margaret Sanger and the birth control movement in America","author":"Chesler","year":"1992"},{"key":"10.1016\/j.beem.2012.11.004_bib4","unstructured":"http: \/\/ www.fda.gov."},{"key":"10.1016\/j.beem.2012.11.004_bib5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0002-9378(58)90722-1","article-title":"Fertility control with oral medication","volume":"75","author":"Pincus","year":"1958","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.11.004_bib6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0002-9378(77)90447-1","article-title":"Implantation of pure crystalline pellets of estradiol for conception control","volume":"127","author":"Greenblatt","year":"1977","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.11.004_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1600-0412.1981.tb00038.x","article-title":"Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation","volume":"60","author":"Serup","year":"1981","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1016\/j.beem.2012.11.004_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0010-7824(97)00006-1","article-title":"Inhibition of ovulation with transdermal estradiol and oral progestogens in perimenopausal women","volume":"55","author":"De Leo","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.004_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0940-2993(98)80034-1","article-title":"Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives","volume":"50","author":"Hoffmann","year":"1998","journal-title":"Experimental and Toxicologic Pathology"},{"key":"10.1016\/j.beem.2012.11.004_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clinthera.2011.11.006","article-title":"Estradiol valerate\/dienogest: a novel combined oral contraceptive","volume":"34","author":"Borgelt","year":"2012","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.beem.2012.11.004_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.11.004_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsbmb.2008.12.013","article-title":"Clinical implications of estetrol","volume":"114","author":"Visser","year":"2009","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.beem.2012.11.004_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.maturitas.2008.11.011","article-title":"Pharmacological profile of progestins","volume":"61","author":"Sitruk-Ware","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2012.11.004_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.04.004","article-title":"The use of newer progestins for contraception","volume":"82","author":"Sitruk-Ware","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.004_bib15","article-title":"Types of progestogens in combined oral contraception: effectiveness and side-effects","volume":"11","author":"Lawrie","year":"2011","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.beem.2012.11.004_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003553.pub2","article-title":"Biphasic versus monophasic oral contraceptives for contraception","volume":"3","author":"Van Vliet","year":"2006","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.beem.2012.11.004_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009038","article-title":"Triphasic versus monophasic oral contraceptives for contraception","volume":"11","author":"Van Vliet","year":"2011","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.beem.2012.11.004_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/humupd\/8.4.345","article-title":"Residual ovarian activity during oral steroid contraception","volume":"8","author":"van Heusden","year":"2002","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.beem.2012.11.004_bib19","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/humrep\/der058","article-title":"Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17 \u03b2 estradiol (NOMAC\/E2): a double-blind, randomized study","volume":"26","author":"Christin-Maitre","year":"2011","journal-title":"Human Reproduction"},{"key":"10.1016\/j.beem.2012.11.004_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/ejc.7.3.155.161","article-title":"Oral contraception: patterns of non-compliance. The Coraliance study","volume":"7","author":"Aubeny","year":"2002","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.11.004_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006260.pub2","article-title":"Immediate start of hormonal contraceptives for contraception","volume":"2","author":"Lopez","year":"2008","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.beem.2012.11.004_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/13625187.2010.529969","article-title":"New regimens with combined oral contraceptive pills-moving away from traditional 21\/7 cycles","volume":"15","author":"Read","year":"2010","journal-title":"The European Journal of Contraception and Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.11.004_bib23","first-page":"235","article-title":"The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20\u00a0\u03bcg\/levonorgestrel 100\u00a0\u03bcg\u00a0+\u00a0ethinyl estradiol 10\u00a0\u03bcg","volume":"2","author":"Krishnan","year":"2010","journal-title":"International Journal of Women's Health"},{"key":"10.1016\/j.beem.2012.11.004_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jfprhc-2011-100213","article-title":"Contraceptive efficacy and tolerability of ethinylestradiol 20\u00a0\u03bcg\/drospirenone 3\u00a0mg in a flexible extended regimen: an open-label, multicentre, randomized, controlled study","volume":"38","author":"Klipping","year":"2012","journal-title":"Journal of Familial Planning and Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.11.004_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.contraception.2011.12.009","article-title":"Bleeding profile of a flexible extended regimen of ethinylestradiol\/drospirenone in US women: an open-label, three-arm, active controlled, muticenter study","volume":"86","author":"Jensen","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.004_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/humrep\/16.3.469","article-title":"Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl estradiol","volume":"16","author":"Roumen","year":"2001","journal-title":"Human Reproduction"},{"key":"10.1016\/j.beem.2012.11.004_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00024677-200302030-00005","article-title":"Transdermal ethinylestradiol\/norelgestromin: a review of its use in hormonal contraception","volume":"2","author":"Goa","year":"2003","journal-title":"Treatments in Endocrinology"},{"key":"10.1016\/j.beem.2012.11.004_bib28","first-page":"53","article-title":"Post coital contraception \u2013 a pilot study","volume":"13","author":"Yuzpe","year":"1974","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1016\/j.beem.2012.11.004_bib29","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/humrep\/16.7.1527","article-title":"Ovarian and endometrial function during hormonal contraception","volume":"16","author":"ESHRE Capri Workshop Group","year":"2001","journal-title":"Human Reproduction"},{"key":"10.1016\/j.beem.2012.11.004_bib30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0039-128X(00)00124-0","article-title":"Progestin implants","volume":"65","author":"Croxatto","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2012.11.004_bib31","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3109\/09513590.2011.652247","article-title":"Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review","volume":"28","author":"Palomba","year":"2012","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.beem.2012.11.004_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.contraception.2011.08.003","article-title":"The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception","volume":"85","author":"Mansour","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.004_bib33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/01443615.2011.611917","article-title":"The emergency contraceptive drug, levonorgestrel: a review of post-coital oral and peri-coital vaginal administration for prevention of pregnancy","volume":"31","author":"Sarkar","year":"2011","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.beem.2012.11.004_bib34","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199210083271501","article-title":"Mifepristone (RU486) compared with high dose estrogen and progestogen for emergency postcoital contraception","volume":"327","author":"Glasier","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2012.11.004_bib35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis","volume":"375","author":"Glasier","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.004_bib36","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2006-2816","article-title":"Effects of the progesterone receptor modulator VA 2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial","volume":"92","author":"Chabbert-Buffet","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.11.004_bib37","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2011.10.003","article-title":"Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women","volume":"85","author":"Brache","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.004_bib38","unstructured":"http:\/\/www.un.org\/esa\/population\/publications\/contraceptive 2011."},{"key":"10.1016\/j.beem.2012.11.004_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(12)60478-4","article-title":"Maternal death averted by contraceptive use: an analysis of 172 countries","volume":"380","author":"Ahmed","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.004_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0140-6736(12)60609-6","article-title":"Contraception and health","volume":"380","author":"Cleland","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.004_bib41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.contraception.2012.05.013","article-title":"Continuing social disparities despite upward trends in sexual and reproductive health service among young women in the United States","volume":"86","author":"Hall","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.004_bib42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.contraception.2012.05.017","article-title":"Types of contraceptives used by US women","volume":"86","author":"Hall","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.004_bib43","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2012.11.004_bib44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/13625187.2011.630492","article-title":"Non-contraceptive benefits of hormonal contraception: time for renewed awareness","volume":"16","author":"Siedman","year":"2011","journal-title":"The European Journal of Contraception and Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.11.004_bib45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.04.002","article-title":"Fertility after discontinuation of contraception: a comprehensive review of literature","volume":"84","author":"Mansour","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.004_bib46","unstructured":"The ESHRE Capri Working group. Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception. Human Reproduction Update 2012 advance access published June 13."},{"key":"10.1016\/j.beem.2012.11.004_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0140-6736(12)61166-0","article-title":"The art of medicine women making contraceptive choices in 20th-century America","volume":"380","author":"Meldrum","year":"2012","journal-title":"Lancet"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X12001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X12001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:45:54Z","timestamp":1761497154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X12001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1521690X12001169"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2012.11.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"History of oral contraceptive drugs and their use worldwide","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2012.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}